Allen Kaasik

Prof. Allen Kaasik


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PWPrzemyslaw Wareski
Przemyslaw Wareski
AVAnnika Vaarmann
Annika Vaarmann
VCVinay Choubey
Vinay Choubey
DSDzhamilja Safiulina
Dzhamilja Safiulina
JLJoanna Liiv
Joanna Liiv
AKAllen Kaasik
Allen Kaasik
Recent studies indicate that regulation of cellular oxidative capacity through enhancing mitochondrial biogenesis may be beneficial for neuronal recovery and survival in human neurodegenerative disorders. The peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) has been shown to be a master regulator of mitochondrial biogenesis and cellular energy metabolism in muscle and liver. The aim of our study was to establish whether PGC-1alpha and PGC-1beta control mitochondrial density also in neurons and if these coactivators could be up-regulated by deacetylation. The results demonstrate that PGC-1alpha and PGC-1beta control mitochondrial capacity in an additive and independent manner. This effect was observed in all studied subtypes of neurons, in cortical, midbrain, and cerebellar granule neurons. We also observed that endogenous neuronal PGC-1alpha but not PGC-1beta could be activated through its repressor domain by suppressing it. Results demonstrate also that overexpression of SIRT1 deacetylase or suppression of GCN5 acetyltransferase activates transcriptional activity of PGC-1alpha in neurons and increases mitochondrial density. These effects were mediated exclusively via PGC-1alpha, since overexpression of SIRT1 or suppression of GCN5 was ineffective where PGC-1alpha was suppressed by short hairpin RNA. Moreover, the results demonstrate that overexpression of PGC-1beta or PGC-1alpha or activation of the latter by SIRT1 protected neurons from mutant alpha-synuclein- or mutant huntingtin-induced mitochondrial loss. These evidences demonstrate that activation or overexpression of the PGC-1 family of coactivators could be used to compensate for neuronal mitochondrial loss and suggest that therapeutic agents activating PGC-1 would be valuable for treating neurodegenerative diseases in which mitochondrial dysfunction and oxidative damage play an important pathogenic role.

1 March 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
VCVinay Choubey
Vinay Choubey
DSDzhamilja Safiulina
Dzhamilja Safiulina
AVAnnika Vaarmann
Annika Vaarmann
MCMichal Cagalinec
Michal Cagalinec
PWPrzemyslaw Wareski
Przemyslaw Wareski
AKAllen Kaasik
Allen Kaasik
Parkinson disease is characterized by the accumulation of aggregated α-synuclein as the major component of the Lewy bodies. α-Synuclein accumulation in turn leads to compensatory effects that may include the up-regulation of autophagy. Another common feature of Parkinson disease (PD) is mitochondrial dysfunction. Here, we provide evidence that the overactivation of autophagy may be a link that connects the intracellular accumulation of α-synuclein with mitochondrial dysfunction. We found that the activation of macroautophagy in primary cortical neurons that overexpress mutant A53T α-synuclein leads to massive mitochondrial destruction and loss, which is associated with a bioenergetic deficit and neuronal degeneration. No mitochondrial removal or net loss was observed when we suppressed the targeting of mitochondria to autophagosomes by silencing Parkin, overexpressing wild-type Mitofusin 2 and dominant negative Dynamin-related protein 1 or blocking autophagy by silencing autophagy-related genes. The inhibition of targeting mitochondria to autophagosomes or autophagy was also partially protective against mutant A53T α-synuclein-induced neuronal cell death. These data suggest that overactivated mitochondrial removal could be one of the contributing factors that leads to the mitochondrial loss observed in PD models.

1 January 2007 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Open access
PDF file
AKAllen Kaasik
Allen Kaasik
DSDzhamilja Safiulina
Dzhamilja Safiulina
AZAlexander Zharkovsky
Alexander Zharkovsky
VVVladimir Veksler
Vladimir Veksler
Mitochondrial volume homeostasis is a housekeeping cellular function essential for maintaining the structural integrity of the organelle. Changes in mitochondrial volume have been associated with a wide range of important biological functions and pathologies. Mitochondrial matrix volume is controlled by osmotic balance between cytosol and mitochondria. Any dysbalance in the fluxes of the main intracellular ion, potassium, will thus affect the osmotic balance between cytosol and the matrix and promote the water movement between these two compartments. It has been hypothesized that activity of potassium efflux pathways exceeds the potassium influx in functioning mitochondria and that potassium concentration in matrix could be actually lower than in cytoplasm. This hypothesis provides a clear-cut explanation for the mitochondrial swelling observed after mitochondrial depolarization, mitochondrial calcium overload, or opening of permeability transition pore. It should also be noted that the rate of water flux into or out of the mitochondrion is determined not only by the osmotic gradient that acts as the driving force for water transport but also by the water permeability of the inner membrane. Recent data suggest that the mitochondrial inner membrane has also specific water channels, aquaporins, which facilitate water movement between cytoplasm and matrix. This review discusses different phases of mitochondrial swelling and summarizes the potential effects of mitochondrial swelling on cell function.

19 July 2016 in PLOS Biology
Verified
Journal Article
Open access
PDF file
MCMichal Cagalinec
Michal Cagalinec
MLMailis Liiv
Mailis Liiv
ZHZuzana Hodurova
Zuzana Hodurova
Miriam A. HickeyMiriam A. Hickey
Miriam A. Hickey
AVAnnika Vaarmann
Annika Vaarmann
AKAllen Kaasik
Allen Kaasik
Deficiency of the protein Wolfram syndrome 1 (WFS1) is associated with multiple neurological and psychiatric abnormalities similar to those observed in pathologies showing alterations in mitochondrial dynamics. The aim of this study was to examine the hypothesis that WFS1 deficiency affects neuronal function via mitochondrial abnormalities. We show that down-regulation of WFS1 in neurons leads to dramatic changes in mitochondrial dynamics (inhibited mitochondrial fusion, altered mitochondrial trafficking, and augmented mitophagy), delaying neuronal development. WFS1 deficiency induces endoplasmic reticulum (ER) stress, leading to inositol 1,4,5-trisphosphate receptor (IP3R) dysfunction and disturbed cytosolic Ca2+ homeostasis, which, in turn, alters mitochondrial dynamics. Importantly, ER stress, impaired Ca2+ homeostasis, altered mitochondrial dynamics, and delayed neuronal development are causatively related events because interventions at all these levels improved the downstream processes. Our data shed light on the mechanisms of neuronal abnormalities in Wolfram syndrome and point out potential therapeutic targets. This work may have broader implications for understanding the role of mitochondrial dynamics in neuropsychiatric diseases. Wolfram syndrome (WS) is a genetic disorder characterized by diabetes insipidus, diabetes mellitus, optic atrophy, deafness, and brain atrophy. Brain abnormalities occur at the earliest stage of clinical symptoms, suggesting that Wolfram syndrome has a pronounced impact on early brain development. The majority of Wolfram syndrome cases are caused by mutations in the gene Wolfram syndrome 1 (WFS1), which encodes for a protein localized to the endoplasmic reticulum (ER) membrane. However, the clinical symptoms of WS resemble mitochondrial disease symptoms, suggesting strong mitochondrial involvement. In this manuscript, we demonstrate that deficiency of the gene WFS1 triggers an ER-stress cascade, which impairs the function of the IP3-receptor calcium channel, leading to altered calcium homeostasis. The latter leads to dysregulation of mitochondrial dynamics, as characterized by augmented mitophagy—a selective degradation of mitochondria—and inhibited mitochondrial trafficking and fusion, which results in lower levels of ATP and, thus, inhibits neuronal development. These results shed new light onto the mechanisms of neuronal abnormalities in Wolfram syndrome and point out potentially new therapeutic targets. Moreover, our results unravel two rather unexpected links that have an impact beyond the relatively rare Wolfram syndrome. First, relatively mild stress of the ER can seriously disturb mitochondrial dynamics, explaining why alterations at the level of the ER could lead to a mitochondrial phenotype. Second, increased levels of mitophagy, leading to excessive and unwanted mitochondrial clearance, are harmful for neurons. Furthermore, since alterations in the gene WFS1 take place in different neurologic and psychiatric disorders, our work may also have broad implications for understanding the role of mitochondrial dynamics in neuropsychiatric diseases.

30 November 2018 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
DSDzhamilja Safiulina
Dzhamilja Safiulina
MKMalle Kuum
Malle Kuum
VCVinay Choubey
Vinay Choubey
NGNana Gogichaishvili
Nana Gogichaishvili
JLJoanna Liiv
Joanna Liiv
AKAllen Kaasik
Allen Kaasik
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

23 December 2021 in Cells
Verified
Journal Article
Open access
PDF file
VCVinay Choubey
Vinay Choubey
AZAkbar Zeb
Akbar Zeb
AKAllen Kaasik
Allen Kaasik
Mitochondria in the cell are the center for energy production, essential biomolecule synthesis, and cell fate determination. Moreover, the mitochondrial functional versatility enables cells to adapt to the changes in cellular environment and various stresses. In the process of discharging its cellular duties, mitochondria face multiple types of challenges, such as oxidative stress, protein-related challenges (import, folding, and degradation) and mitochondrial DNA damage. They mitigate all these challenges with robust quality control mechanisms which include antioxidant defenses, proteostasis systems (chaperones and proteases) and mitochondrial biogenesis. Failure of these quality control mechanisms leaves mitochondria as terminally damaged, which then have to be promptly cleared from the cells before they become a threat to cell survival. Such damaged mitochondria are degraded by a selective form of autophagy called mitophagy. Rigorous research in the field has identified multiple types of mitophagy processes based on targeting signals on damaged or superfluous mitochondria. In this review, we provide an in-depth overview of mammalian mitophagy and its importance in human health and diseases. We also attempted to highlight the future area of investigation in the field of mitophagy.